

Twist Bioscience (TWST) shares fell Thursday after a 2027 outlook signaled slower AI drug discovery growth, overshadowing a strong Q4 beat.
You can purchase shares of Twist Bioscience (NASDAQ:TWST) through any online brokerage.
Other companies in Twist Bioscience’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Twist Bioscience has a consensus price target of $98.95.
The stock price for Twist Bioscience (NASDAQ: TWST) is $105.01 last updated November 20, 2026 at 7:50 PM EST.
There are no upcoming dividends for Twist Bioscience.
Twist Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Twist Bioscience.
Twist Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Twist Bioscience Corp provides customizable solutions across the biological continuum, helping customers read, write and innovate in biology. The core of its business is a proprietary platform that allows it to manufacture synthetic DNA by writing...